NCT06524284View on ClinicalTrials.gov

Feasibility of Self-treatment of Painful Diabetic Neuropathy Using Electrical Vasomotor Nerve Stimulation

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 22, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2024

Conditions
Painful Diabetic Neuropathy
Interventions
DEVICE

Releaf

10 days/35 minutes per day EVNS (non-invasive electrostimulation) treatment on lower legs and feet by the subject or its caregiver after instruction by the podiatrist.

Trial Locations (1)

Unknown

RECRUITING

Neurecon, Vught

Sponsors

Lead Sponsor

Neurecon BV
All Listed Sponsors
lead

Neurecon BV

INDUSTRY

NCT06524284 - Feasibility of Self-treatment of Painful Diabetic Neuropathy Using Electrical Vasomotor Nerve Stimulation | Biotech Hunter | Biotech Hunter